Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Amgen (AMGN) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2010. Compare with AMGN stock chart to see long term trends.

AMGN stock compared to

AMGN Income Statement

Revenue, Net:5901000000
Revenue Per Share:10.23
Cost of Goods & Services Sold:1490000000
Selling, General & Admin Expense:1254000000
Research & Development Expense:967000000
Total Operating Expenses:3772000000
Operating Income:2129000000
Income Taxes:211000000
Net Income:1646000000
Earnings Per Share, Basic:2.85
Shares Outstanding, Basic Avg:577000000

AMGN Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:841000000
Change in Accounts Receiveable:-91000000
Net Cash from Operations:2104000000
Repurchases/Buybacks Common Stock:871000000
Issuance of Long-term Debt:0
Cash Dividends Paid:1016000000
Net Cash from Financing Activities:-1939000000
Property, Plant & Equipment Purchases:166000000
Net Cash from Investing Activities:-319000000
Net Change in Cash & Equivalents:-154000000

AMGN Balance Sheet

Cash and Cash Equivalents:6112000000
Accounts Receivable, Net:4423000000
Inventories:4017000000
Total Current Assets:21299000000
Property, Plant & Equipment, Net:4855000000
Total Assets:62539000000
Accounts Payable:1396000000
Current Portion of Long-Term Debt:1556000000
Total Short-Term Liabilities:12869000000
Long Term Debt, Non-Current Portion:31129000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
47,985,428 sh
-744,156 sh
-2%
$12,195,975
$702,615
Vanguard Group Inc
47,937,060 sh
-929,108 sh
-2%
$12,183,683
$658,108
Primecap Management Co/Ca/
17,407,082 sh
-555,848 sh
-3%
$4,424,184
$187,447
FMR LLC
14,202,206 sh
-2,892,089 sh
-17%
$3,609,633
-$422,229
Morgan Stanley
8,565,891 sh
561,293 sh
7%
$2,177,107
$289,142
Northern Trust Corp
8,138,181 sh
159,771 sh
2%
$2,068,400
$186,612
Bank Of America Corp /De/
7,177,015 sh
7,116,615 sh
11783%
$1,824,111
$1,809,865
Aristotle Capital Management, LLC
4,167,910 sh
59,300 sh
1%
$1,058,665
$89,608
Legal & General Group Plc
3,998,865 sh
-24,154 sh
-1%
$1,016,349
$67,543
Wellington Management Group Llp
3,805,485 sh
-37,686 sh
-1%
$967,201
$60,751
Royal Bank Of Canada
3,709,795 sh
111,149 sh
3%
$942,881
$94,104
Price T Rowe Associates Inc /Md/
3,585,655 sh
18,576 sh
1%
$911,330
$69,999
UBS Asset Management Americas Inc
3,347,273 sh
-76,895 sh
-2%
$850,742,905
$43,118,643
Invesco Ltd.
3,181,872 sh
861,772 sh
37%
$808,704
$261,484
Charles Schwab Investment Management Inc
2,756,381 sh
-44,454 sh
-2%
$700,563
$39,958
Goldman Sachs Group Inc
2,097,573 sh
1,985,773 sh
1776%
$533,119
$506,750
Ameriprise Financial Inc
1,594,432 sh
70,268 sh
5%
$405,666
$46,133
Credit Suisse Ag/
1,395,852 sh
1,237,852 sh
783%
$354,770
$317,504
Amundi Pioneer Asset Management Inc
1,283,950 sh
128,398 sh
11%
$326,331
$53,792
American Century Companies Inc
1,201,528 sh
-44,655 sh
-4%
$305,380
$11,455

Data imported from Amgen Inc SEC filings. Check original filings before making any investment decision.